Patents Assigned to Stromagene Corporation
  • Gene therapy using stromal cells
    Patent number: 5849287
    Abstract: A method of causing production and secretion into the bloodsream of a human patient of a biologically active enzyme for which the human patient suffers a deficiency; the method involves introducing into the human patient donor bone marrow stromal cells which have been transfected with a gene encoding the enzyme, so that the introduced cells can adhere to a bone cavity surface of the patient and produce and secrete the active enzyme.
    Type: Grant
    Filed: March 22, 1995
    Date of Patent: December 15, 1998
    Assignees: Stromagene Corporation, Gene Therapy Sciences, Inc.
    Inventors: Joel S. Greenberger, Peter H. Levine